ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $353,310,000 | +195.9% | 51,428 | +151.5% | 0.03% | +225.0% |
Q3 2015 | $119,416,000 | -61.9% | 20,448 | -46.0% | 0.01% | -55.6% |
Q2 2015 | $313,210,000 | -7.1% | 37,873 | -7.5% | 0.02% | -5.3% |
Q1 2015 | $337,247,000 | -4.5% | 40,928 | -20.4% | 0.02% | -9.5% |
Q4 2014 | $353,310,000 | – | 51,428 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |